MMP1 and breast cancer: 15d-PGJ2 inhibited the invasive capacities of MDA-MB-231 human breast cancer cells via by upregulating a tissue inhibitor of matrix metalloproteinase-1 and decreasing gelatinase activity in conditioned media [17].